相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activating transcription factor 4 regulates hypoxia inducible factor 1α in chronic hypoxia in pancreatic cancer cells
Nancy T. Chee et al.
ONCOLOGY REPORTS (2023)
miR-222-3p-containing macrophage-derived extracellular vesicles confer gemcitabine resistance via TSC1-mediated mTOR/AKT/PI3K pathway in pancreatic cancer
Yao Guo et al.
CELL BIOLOGY AND TOXICOLOGY (2023)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis
Chonghui Hu et al.
MOLECULAR CANCER (2022)
SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression
Estefania Carrasco-Garcia et al.
CANCERS (2022)
The Roles of microRNAs in Cancer Multidrug Resistance
Lucia Pavlikova et al.
CANCERS (2022)
Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
Annalisa Comandatore et al.
DIAGNOSTICS (2022)
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
Jianyou Gu et al.
MOLECULAR CANCER (2022)
Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer
Madeleine M. LaRue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
microRNA-497 prevents pancreatic cancer stem cell gemcitabine resistance, migration, and invasion by directly targeting nuclear factor kappa B 1
Qiangfeng Yu et al.
Aging-US (2022)
Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes
Katherine E. Richards et al.
CANCERS (2022)
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Daiyong Deng et al.
CELLS (2022)
Tumor microenvironment and metabolic remodeling in gemcitabine-based chemoresistance of pancreatic cancer
Zongting Gu et al.
CANCER LETTERS (2021)
Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development
Ga-Ram Hwang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal
Yue Pan et al.
PANCREAS (2021)
PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer
Yun-Fei Liu et al.
PANCREAS (2021)
Targeting and Reprograming Cancer-Associated Fibroblasts and the Tumor Microenvironment in Pancreatic Cancer
Yoshiaki Sunami et al.
CANCERS (2021)
Pharmacoethnicity of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: a systematic review and meta-analysis
Yoon Suk Lee et al.
SCIENTIFIC REPORTS (2021)
EMT-associated microRNAs and their roles in cancer stemness and drug resistance
Guangtao Pan et al.
CANCER COMMUNICATIONS (2021)
MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism
An Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis
Shuo Yu et al.
GENES (2021)
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
Karen Aughton et al.
CANCERS (2021)
Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts
Farhana Mollah et al.
BIOMEDICINES (2021)
Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and ABCC1 transactivation
Lusheng Wei et al.
CELL DEATH & DISEASE (2021)
Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
Iman M. Ahmad et al.
CANCERS (2021)
Interleukin-6 participates in human pancreatic stellate cell activation and collagen I production via TGF-β1/Smad pathway
Meifang Zheng et al.
CYTOKINE (2021)
Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer
Takuya Oba et al.
SCIENTIFIC REPORTS (2021)
Extracellular Vesicle-Associated miRNAs and Chemoresistance: A Systematic Review
America Campos et al.
CANCERS (2021)
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside
Md. Hafiz Uddin et al.
CANCERS (2021)
MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer
Jun Okazaki et al.
DIGESTION (2020)
ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells
Mingyang Liu et al.
GASTROENTEROLOGY (2020)
Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210
Zhiyong Yang et al.
CELLULAR ONCOLOGY (2020)
HALO 109-301: A randomized, double-blind, placebo-controlled, phase 3 study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients (pts) with previously untreated hyaluronan (HA)-high metastatic pancreatic ductal adenocarcinoma (mPDA).
Margaret A. Tempero et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Cheng Qin et al.
MOLECULAR CANCER (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
MiR-301a transcriptionally activated by HIF-2 alpha promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer
Kun-Dong Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities
Won Jin Ho et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer
Shingo Kato et al.
CANCERS (2020)
A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies
Alexis Forterre et al.
CANCERS (2020)
Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance
Patrick Santos et al.
CELLS (2020)
Low-intensity low-frequency ultrasound enhances the chemosensitivity of gemcitabine-resistant ASPC-1 cells via PI3K/AKT/NF-κB pathway-mediated ABC transporters
Fuqiang Qiu et al.
ONCOLOGY REPORTS (2020)
Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy
Xiaofei Xin et al.
SCIENCE ADVANCES (2020)
MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/β-Catenin Signal via ST7L
Ting Zhan et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy
Huimin Lu et al.
BIOSCIENCE REPORTS (2019)
MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway
Tingting Wang et al.
CELL DEATH & DISEASE (2019)
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis
Sara Pusceddu et al.
CANCERS (2019)
Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
Manoj Amrutkar et al.
BMC CANCER (2019)
Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer
Yuan Fang et al.
EXPERIMENTAL CELL RESEARCH (2019)
miRNA Predictors of Pancreatic Cancer Chemotherapeutic Response: A Systematic Review and Meta-Analysis
Madhav Madurantakam Royam et al.
CANCERS (2019)
Chemoresistance in Pancreatic Cancer
Siyuan Zeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A gene regulatory network to control EMT programs in development and disease
Hassan Fazilaty et al.
NATURE COMMUNICATIONS (2019)
Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia
Jun Ni et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2019)
Prognostic Role of High-Grade Tumor Budding in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis with a Focus on Epithelial to Mesenchymal Transition
Rita T. Lawlor et al.
CANCERS (2019)
miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn
Guodong Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Tumor-Stroma IL1 beta-IRAK4 Feedforward Circuitry DrivesTumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer
Daoxiang Zhang et al.
CANCER RESEARCH (2018)
miR-301a plays a pivotal role in hypoxia-induced gemcitabine resistance in pancreatic cancer
Guangtao Luo et al.
EXPERIMENTAL CELL RESEARCH (2018)
MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
Guangbing Xiong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer
Lulin Zhang et al.
ONCOLOGY RESEARCH (2018)
EMT: Mechanisms and therapeutic implications
Mohini Singh et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer
Yuichiro Okumura et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future
Aline Barhli et al.
DIGESTIVE AND LIVER DISEASE (2018)
Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages
Sachin Kumar Deshmukh et al.
SCIENTIFIC REPORTS (2018)
Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
Shin-Heng Chiou et al.
SCIENTIFIC REPORTS (2018)
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
Nikolaos Tsesmetzis et al.
CANCERS (2018)
Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
Sameer Abdallah Dhayat et al.
CANCERS (2018)
Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer
Lusheng Wei et al.
CELL DEATH & DISEASE (2018)
Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
K. E. Richards et al.
ONCOGENE (2017)
Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma
Zhiyi Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1
Qiangsheng Hu et al.
ONCOLOGY REPORTS (2017)
Prognostic Implications of Expression Profiling for Gemcitabine-Related Genes (hENT1, dCK, RRM1, RRM2) in Patients With Resectable Pancreatic Adenocarcinoma Receiving Adjuvant Chemotherapy
Marek Sierzega et al.
PANCREAS (2017)
miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis
Rui-Meng Yang et al.
CELL DEATH & DISEASE (2017)
Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells
A. J. Rice et al.
ONCOGENESIS (2017)
Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment
Huey-Jen Lin et al.
CANCERS (2017)
EMT and Treatment Resistance in Pancreatic Cancer
Nicola Gaianigo et al.
CANCERS (2017)
Dysregulation of miRNA Expression in Cancer Associated Fibroblasts (CAFs) and Its Consequences on the Tumor Microenvironment
Maren Schoepp et al.
CANCERS (2017)
Pancreatic Cancer Chemoresistance to Gemcitabine
Manoj Amrutkar et al.
CANCERS (2017)
MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
Manabu Mikamori et al.
SCIENTIFIC REPORTS (2017)
miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
Hidekazu Hiramoto et al.
SCIENTIFIC REPORTS (2017)
Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going
Chen Liang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells
Azam Rajabpour et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205
Amit Kumar Chaudhary et al.
CANCER LETTERS (2017)
miR-153 enhances the therapeutic effect of gemcitabine by targeting Snail in pancreatic cancer
Feng Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
A role of pancreatic stellate cells in islet fibrosis and β-cell dysfunction in type 2 diabetes mellitus
Esder Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
microRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer
Prince Saforo Amponsah et al.
CANCER LETTERS (2017)
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
Girijesh Kumar Patel et al.
BRITISH JOURNAL OF CANCER (2017)
Matrix control of pancreatic cancer: New insights into fibronectin signaling
Mary Topalovski et al.
CANCER LETTERS (2016)
MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer
Pei Fan et al.
CANCER LETTERS (2016)
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
Shouhui Yang et al.
CANCER RESEARCH (2016)
Role of immune cells in pancreatic cancer from bench to clinical application An updated review
Jae Hyuck Chang et al.
MEDICINE (2016)
Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling
J. Li et al.
ONCOGENE (2016)
Nutlin-3 reverses the epithelial-mesenchymal transition in gemcitabine-resistant hepatocellular carcinoma cells
Qiong Wu et al.
ONCOLOGY REPORTS (2016)
MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma
Yue Fan et al.
SCIENTIFIC REPORTS (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: Overcoming transport defects using a nanoparticle approach
Sau Wai Hung et al.
CANCER LETTERS (2015)
The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)
Francesca Vena et al.
CLINICAL CANCER RESEARCH (2015)
Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer
Nagaraj S. Nagathihalli et al.
GASTROENTEROLOGY (2015)
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells
Michele Cioffi et al.
GUT (2015)
miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer
Wen-Long Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer A Systematic Review and Meta-Analysis
Doudou Li et al.
MEDICINE (2015)
Quantitative Targeted Proteomics of Pancreatic Cancer: Deoxycytidine Kinase Protein Level Correlates to Progression-Free Survival of Patients Receiving Gemcitabine Treatment
Ken Ohmine et al.
MOLECULAR PHARMACEUTICS (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
HES 1 is essential for chemoresistance induced by stellate cells and is associated with poor prognosis in pancreatic cancer
Feng Cao et al.
ONCOLOGY REPORTS (2015)
被撤回的出版物: MicroRNA-153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma (Retracted article. See vol. 49, pg. 7, 2023)
Zhenghai Bai et al.
ONCOLOGY REPORTS (2015)
Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
Jia Ma et al.
ONCOTARGET (2015)
MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
S. Hasegawa et al.
BRITISH JOURNAL OF CANCER (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis
Ole Helm et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells
Naotake Funamizu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
MIR-211 MODULATES GEMCITABINE ACTIVITY THROUGH DOWNREGULATION OF RIBONUCLEOTIDE REDUCTASE AND INHIBITS THE INVASIVE BEHAVIOR OF PANCREATIC CANCER CELLS
Mina Maftouh et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2014)
Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition
J. Park et al.
ONCOGENE (2014)
Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase
N. Weizman et al.
ONCOGENE (2014)
Cholangiocarcinoma cell line TK may be useful for the pharmacokinetic study of the chemotherapeutic agent gemcitabine
Minori Kamada et al.
ONCOLOGY REPORTS (2014)
Alteration of the microRNA expression profile during the activation of pancreatic stellate cells
Atsushi Masamune et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem et al.
CANCER RESEARCH (2013)
Targeting microRNAs in Pancreatic Cancer: Microplayers in the Big Game
Sheema Khan et al.
CANCER RESEARCH (2013)
Therapeutic Advances in Pancreatic Cancer
Andrew Scott Paulson et al.
GASTROENTEROLOGY (2013)
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma
Naotake Funamizu et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells
Thomas A. Mace et al.
JOURNAL OF SURGICAL RESEARCH (2013)
The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL
Peng Wang et al.
MOLECULAR ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
N. Skrypek et al.
ONCOGENE (2013)
Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer: A Systematic Review with Meta-Analysis
Zu-Yao Yang et al.
PLOS ONE (2013)
Differential Processing of let-7a Precursors Influences RRM2 Expression and Chemosensitivity in Pancreatic Cancer: Role of LIN-28 and SET Oncoprotein
Yangzom Doma Bhutia et al.
PLOS ONE (2013)
MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
Brian E. Kadera et al.
PLOS ONE (2013)
The Pancreas Cancer Microenvironment
Christine Feig et al.
CLINICAL CANCER RESEARCH (2012)
Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition
Karl Quint et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
Michela Garofalo et al.
NATURE MEDICINE (2012)
Hydroxyurea Decreases Gemcitabine Resistance in Pancreatic Carcinoma Cells With Highly Expressed Ribonucleotide Reductase
Naotake Funamizu et al.
PANCREAS (2012)
DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma
Geng Zhang et al.
PLOS ONE (2012)
Tetrahydrouridine Inhibits Cell Proliferation through Cell Cycle Regulation Regardless of Cytidine Deaminase Expression Levels
Naotake Funamizu et al.
PLOS ONE (2012)
Pancreatic Cancer Cells Enhance the Ability of Collagen Internalization during Epithelial-Mesenchymal Transition
Naoki Ikenaga et al.
PLOS ONE (2012)
Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment
Bin Bao et al.
PLOS ONE (2012)
MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
Kenoki Ohuchida et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP-Mediated Expression of HMGA2
Surabhi Dangi-Garimella et al.
CANCER RESEARCH (2011)
CNT1 Expression Influences Proliferation and Chemosensitivity in Drug-Resistant Pancreatic Cancer Cells
Yangzom D. Bhutia et al.
CANCER RESEARCH (2011)
Stromal biology and therapy in pancreatic cancer
Albrecht Neesse et al.
GUT (2011)
Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer-a review
Sameer Dhayat et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Association of Cytidine Deaminase and Xeroderma Pigmentosum Group D Polymorphisms with Response, Toxicity, and Survival in Cisplatin/Gemcitabine-Treated Advanced Non-small Cell Lung Cancer Patients
Vienna Ludovini et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells
Kazuhiro Kikuta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations
F. Wang et al.
BRITISH JOURNAL OF CANCER (2010)
Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression
Seth B. Krantz et al.
Cancers (2010)
Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma
Wolfgang Hagmann et al.
Cancers (2010)
Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Harald J. Maier et al.
Cancers (2010)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
Zhiwei Wang et al.
CANCER RESEARCH (2009)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
Raphael Marechal et al.
CLINICAL CANCER RESEARCH (2009)
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
James J. Farrell et al.
GASTROENTEROLOGY (2009)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Ulrich Wellner et al.
NATURE CELL BIOLOGY (2009)
Antisense Inhibition of microRNA-21 or-221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
Jong-Kook Park et al.
PANCREAS (2009)
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Qing Ji et al.
PLOS ONE (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer
C. W. Michalski et al.
BRITISH JOURNAL OF CANCER (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Development and characterization of gemcitabine-resistant pancreatic tumor cells
Ami N. Shah et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion
Shereen Keleg et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
Shin Nakahira et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells
Syu-ichi Kanno et al.
CLINICA CHIMICA ACTA (2007)
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine
E Giovannetti et al.
CANCER RESEARCH (2006)
Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation
S Bagga et al.
CELL (2005)
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
C Louvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Tumor-stroma interaction of human pancreatic cancer: Acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins
H Miyamoto et al.
PANCREAS (2004)
Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer
MS Duxbury et al.
SURGERY (2004)
分享论文
